- Home
- BEPC vs ALKS Comparison
BEPC vs ALKS Comparison
Compare BEPC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEPC
- ALKS
- Stock Information
- Founded
- BEPC 2019
- ALKS 1987
- Country
- BEPC United States
- ALKS Ireland
- Employees
- BEPC N/A
- ALKS N/A
- Industry
- BEPC Electric Utilities: Central
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- BEPC Utilities
- ALKS Health Care
- Exchange
- BEPC Nasdaq
- ALKS Nasdaq
- Market Cap
- BEPC 5.1B
- ALKS 4.7B
- IPO Year
- BEPC N/A
- ALKS 1991
- Fundamental
- Price
- BEPC $25.35
- ALKS $29.47
- Analyst Decision
- BEPC Buy
- ALKS Buy
- Analyst Count
- BEPC 1
- ALKS 11
- Target Price
- BEPC $34.00
- ALKS $36.00
- AVG Volume (30 Days)
- BEPC 900.9K
- ALKS 1.5M
- Earning Date
- BEPC 01-31-2025
- ALKS 02-13-2025
- Dividend Yield
- BEPC 5.60%
- ALKS N/A
- EPS Growth
- BEPC N/A
- ALKS 55.25
- EPS
- BEPC N/A
- ALKS 1.97
- Revenue
- BEPC $4,754,000,000.00
- ALKS $1,505,121,000.00
- Revenue This Year
- BEPC $35.62
- ALKS N/A
- Revenue Next Year
- BEPC $6.12
- ALKS N/A
- P/E Ratio
- BEPC N/A
- ALKS $12.89
- Revenue Growth
- BEPC 18.32
- ALKS N/A
- 52 Week Low
- BEPC $21.35
- ALKS $22.90
- 52 Week High
- BEPC $35.14
- ALKS $32.88
- Technical
- Relative Strength Index (RSI)
- BEPC 30.38
- ALKS 53.54
- Support Level
- BEPC $25.82
- ALKS $28.28
- Resistance Level
- BEPC $26.81
- ALKS $29.36
- Average True Range (ATR)
- BEPC 0.95
- ALKS 0.70
- MACD
- BEPC -0.21
- ALKS 0.05
- Stochastic Oscillator
- BEPC 5.74
- ALKS 75.64
About BEPC Brookfield Renewable Corporation
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 20 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.